Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | VEGF | 375.0 | 53 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | VEGF | 437.0 | 45 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | VEGF | 580.0 | 59 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | VEGF | 678.0 | 59 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | VEGF | 702.0 | 64 | ||||
RA2159 | 2 | VEGF | 827.0 | 67 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | VEGF | 424.0 | 49 | ||||
N2645 | 2 | VEGF | 460.0 | 49 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | VEGF | 781.0 | 37 | ||||
RA2708 | 2 | VEGF | 690.0 | 38 | |||||||
0 | VEGF | 66.5 | 40 | ||||||||
0 | VEGF | 56.0 | 41 | ||||||||
0 | VEGF | 52.0 | 51 | ||||||||
0 | VEGF | 46.0 | 39 | ||||||||
0 | VEGF | 46.0 | 62 | ||||||||
0 | VEGF | 38.5 | 40 | ||||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | VEGF | 642.0 | 45 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | VEGF | 1149.0 | 65 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | VEGF | 678.0 | 57 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | VEGF | 776.0 | 68 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | VEGF | 1005.0 | 50 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | VEGF | 1137.0 | 54 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | VEGF | 735.0 | 61 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | VEGF | 1001.0 | 61 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | VEGF | 1203.0 | 70 |